Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Indians, North American | 14 | 2022 | 355 | 3.820 |
Why?
|
Tuberculosis, Multidrug-Resistant | 39 | 2016 | 912 | 3.430 |
Why?
|
Antitubercular Agents | 37 | 2016 | 1320 | 3.000 |
Why?
|
Directly Observed Therapy | 11 | 2018 | 137 | 2.550 |
Why?
|
Peru | 45 | 2023 | 882 | 2.410 |
Why?
|
Community-Institutional Relations | 7 | 2020 | 204 | 2.370 |
Why?
|
Tuberculosis | 20 | 2016 | 1914 | 2.010 |
Why?
|
Antiretroviral Therapy, Highly Active | 9 | 2019 | 1872 | 1.710 |
Why?
|
Community Health Services | 8 | 2020 | 650 | 1.410 |
Why?
|
HIV Infections | 24 | 2023 | 16715 | 1.360 |
Why?
|
Fruit | 3 | 2021 | 1141 | 1.150 |
Why?
|
Vegetables | 3 | 2021 | 1181 | 1.140 |
Why?
|
Alcoholism | 7 | 2016 | 1907 | 1.070 |
Why?
|
Program Evaluation | 8 | 2020 | 2483 | 1.070 |
Why?
|
Mycobacterium tuberculosis | 18 | 2016 | 1832 | 0.960 |
Why?
|
Naltrexone | 4 | 2013 | 307 | 0.920 |
Why?
|
Russia | 13 | 2016 | 408 | 0.870 |
Why?
|
Tuberculosis, Pulmonary | 14 | 2016 | 811 | 0.860 |
Why?
|
Social Support | 10 | 2022 | 2118 | 0.850 |
Why?
|
Food Supply | 5 | 2022 | 524 | 0.790 |
Why?
|
Diabetes Mellitus | 5 | 2020 | 5752 | 0.780 |
Why?
|
Health Services, Indigenous | 2 | 2018 | 42 | 0.730 |
Why?
|
Extensively Drug-Resistant Tuberculosis | 3 | 2010 | 92 | 0.730 |
Why?
|
Drug Resistance, Multiple, Bacterial | 9 | 2014 | 564 | 0.720 |
Why?
|
Poverty | 10 | 2023 | 2660 | 0.710 |
Why?
|
Nutritional Requirements | 1 | 2021 | 286 | 0.710 |
Why?
|
New Mexico | 5 | 2020 | 86 | 0.670 |
Why?
|
Nutritive Value | 1 | 2021 | 339 | 0.640 |
Why?
|
Pregnancy in Diabetics | 1 | 2018 | 179 | 0.580 |
Why?
|
Patient Participation | 4 | 2020 | 1457 | 0.570 |
Why?
|
Delivery of Health Care, Integrated | 3 | 2019 | 941 | 0.530 |
Why?
|
Patient Acceptance of Health Care | 2 | 2020 | 3020 | 0.520 |
Why?
|
Arizona | 3 | 2020 | 108 | 0.520 |
Why?
|
Utah | 3 | 2020 | 126 | 0.520 |
Why?
|
Financial Management | 2 | 2022 | 160 | 0.510 |
Why?
|
Parenting | 1 | 2021 | 678 | 0.510 |
Why?
|
Southwestern United States | 3 | 2020 | 37 | 0.500 |
Why?
|
Antibiotics, Antitubercular | 3 | 2005 | 103 | 0.480 |
Why?
|
Professional Role | 1 | 2017 | 306 | 0.480 |
Why?
|
Urban Population | 4 | 2011 | 2021 | 0.470 |
Why?
|
Alcohol Deterrents | 1 | 2013 | 39 | 0.450 |
Why?
|
Health Education | 1 | 2020 | 1056 | 0.440 |
Why?
|
Needs Assessment | 3 | 2016 | 1146 | 0.440 |
Why?
|
Qualitative Research | 8 | 2022 | 2682 | 0.430 |
Why?
|
Clinical Laboratory Information Systems | 5 | 2014 | 108 | 0.420 |
Why?
|
Microbial Sensitivity Tests | 12 | 2016 | 1870 | 0.420 |
Why?
|
Viral Load | 3 | 2023 | 3300 | 0.410 |
Why?
|
Medication Adherence | 4 | 2022 | 2063 | 0.410 |
Why?
|
United States Indian Health Service | 1 | 2012 | 32 | 0.400 |
Why?
|
Residence Characteristics | 4 | 2018 | 2050 | 0.400 |
Why?
|
Laboratories | 5 | 2014 | 462 | 0.400 |
Why?
|
AIDS-Related Opportunistic Infections | 4 | 2012 | 656 | 0.400 |
Why?
|
Social Stigma | 2 | 2014 | 701 | 0.380 |
Why?
|
Anti-HIV Agents | 4 | 2023 | 4255 | 0.360 |
Why?
|
Pregnancy Complications, Infectious | 3 | 2009 | 2027 | 0.360 |
Why?
|
Adult | 54 | 2023 | 213889 | 0.360 |
Why?
|
Behavior Therapy | 2 | 2013 | 862 | 0.360 |
Why?
|
Humans | 111 | 2023 | 743811 | 0.350 |
Why?
|
Social Justice | 1 | 2014 | 457 | 0.340 |
Why?
|
Child Development | 2 | 2022 | 2212 | 0.340 |
Why?
|
Tuberculosis, Central Nervous System | 1 | 2008 | 16 | 0.330 |
Why?
|
Tuberculosis, Cutaneous | 1 | 2008 | 17 | 0.330 |
Why?
|
Patient Compliance | 6 | 2022 | 2683 | 0.330 |
Why?
|
Female | 66 | 2023 | 380020 | 0.320 |
Why?
|
Male | 61 | 2023 | 349776 | 0.310 |
Why?
|
Rifampin | 2 | 2011 | 315 | 0.300 |
Why?
|
Cause of Death | 1 | 2017 | 3580 | 0.290 |
Why?
|
Verbal Behavior | 1 | 2008 | 340 | 0.290 |
Why?
|
Health Personnel | 3 | 2020 | 3217 | 0.290 |
Why?
|
Stereotyping | 1 | 2008 | 241 | 0.280 |
Why?
|
Patient Care Management | 1 | 2009 | 306 | 0.280 |
Why?
|
Treatment Outcome | 26 | 2023 | 63042 | 0.270 |
Why?
|
Counseling | 4 | 2019 | 1523 | 0.270 |
Why?
|
Career Choice | 1 | 2012 | 743 | 0.260 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2020 | 11729 | 0.260 |
Why?
|
Middle Aged | 32 | 2023 | 213241 | 0.260 |
Why?
|
Psychometrics | 1 | 2014 | 3000 | 0.260 |
Why?
|
HIV | 2 | 2012 | 1604 | 0.250 |
Why?
|
Health Status | 4 | 2023 | 4031 | 0.250 |
Why?
|
Interviews as Topic | 6 | 2020 | 2538 | 0.240 |
Why?
|
Public Health | 2 | 2022 | 2603 | 0.240 |
Why?
|
Patient Readmission | 1 | 2018 | 3117 | 0.240 |
Why?
|
Language | 2 | 2014 | 1468 | 0.230 |
Why?
|
Psychoses, Substance-Induced | 1 | 2004 | 96 | 0.230 |
Why?
|
Cycloserine | 1 | 2004 | 112 | 0.230 |
Why?
|
Mental Health | 3 | 2022 | 3012 | 0.230 |
Why?
|
Prevalence | 8 | 2023 | 15211 | 0.230 |
Why?
|
Rural Population | 3 | 2022 | 2207 | 0.220 |
Why?
|
Young Adult | 14 | 2023 | 56392 | 0.220 |
Why?
|
Hypokalemia | 1 | 2004 | 153 | 0.220 |
Why?
|
Narcotic Antagonists | 3 | 2013 | 562 | 0.220 |
Why?
|
Prisoners | 1 | 2006 | 297 | 0.220 |
Why?
|
Drug Resistance, Multiple | 2 | 2003 | 251 | 0.220 |
Why?
|
HIV Seropositivity | 1 | 2008 | 971 | 0.210 |
Why?
|
DNA-Directed RNA Polymerases | 1 | 2005 | 371 | 0.210 |
Why?
|
Primary Health Care | 2 | 2022 | 4556 | 0.210 |
Why?
|
Focus Groups | 3 | 2022 | 1320 | 0.210 |
Why?
|
Nutrition Disorders | 1 | 2023 | 211 | 0.210 |
Why?
|
Attitude of Health Personnel | 2 | 2017 | 3839 | 0.210 |
Why?
|
Developing Countries | 8 | 2020 | 2815 | 0.210 |
Why?
|
Drug Therapy, Combination | 9 | 2016 | 6487 | 0.210 |
Why?
|
Program Development | 4 | 2012 | 1314 | 0.200 |
Why?
|
Food | 2 | 2023 | 771 | 0.190 |
Why?
|
Retrospective Studies | 26 | 2023 | 77410 | 0.190 |
Why?
|
Sputum | 6 | 2016 | 476 | 0.190 |
Why?
|
Taxes | 1 | 2023 | 221 | 0.190 |
Why?
|
Medically Underserved Area | 3 | 2012 | 252 | 0.190 |
Why?
|
Proportional Hazards Models | 8 | 2017 | 12354 | 0.190 |
Why?
|
Organizations, Nonprofit | 2 | 2020 | 104 | 0.180 |
Why?
|
Adolescent | 23 | 2023 | 85729 | 0.180 |
Why?
|
Health Promotion | 3 | 2022 | 2205 | 0.180 |
Why?
|
Commerce | 2 | 2022 | 592 | 0.180 |
Why?
|
Trust | 2 | 2017 | 505 | 0.170 |
Why?
|
Beverages | 2 | 2023 | 820 | 0.170 |
Why?
|
Sex Distribution | 3 | 2011 | 2298 | 0.170 |
Why?
|
Mass Screening | 3 | 2011 | 5251 | 0.170 |
Why?
|
Brain Diseases | 1 | 2008 | 1558 | 0.170 |
Why?
|
Methicillin Resistance | 1 | 1999 | 198 | 0.160 |
Why?
|
Caregivers | 2 | 2023 | 2098 | 0.160 |
Why?
|
Physicians | 3 | 2013 | 4569 | 0.150 |
Why?
|
Sexual Partners | 1 | 2022 | 728 | 0.150 |
Why?
|
Cohort Studies | 15 | 2023 | 40545 | 0.150 |
Why?
|
Combined Modality Therapy | 5 | 2016 | 8637 | 0.150 |
Why?
|
Prescriptions | 1 | 2020 | 387 | 0.150 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2003 | 685 | 0.150 |
Why?
|
Infant | 8 | 2022 | 35122 | 0.150 |
Why?
|
Government Regulation | 1 | 2021 | 522 | 0.150 |
Why?
|
Alcohol-Related Disorders | 2 | 2010 | 234 | 0.140 |
Why?
|
Psychology | 2 | 2009 | 356 | 0.140 |
Why?
|
Pilot Projects | 3 | 2022 | 8316 | 0.140 |
Why?
|
Postnatal Care | 1 | 2018 | 236 | 0.140 |
Why?
|
Geography | 1 | 2018 | 669 | 0.140 |
Why?
|
Risk Factors | 13 | 2023 | 72252 | 0.140 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1680 | 0.130 |
Why?
|
Child, Preschool | 12 | 2023 | 40964 | 0.130 |
Why?
|
Professional-Patient Relations | 2 | 2020 | 737 | 0.130 |
Why?
|
Aged | 12 | 2023 | 163178 | 0.130 |
Why?
|
United States | 11 | 2023 | 69859 | 0.130 |
Why?
|
Adaptation, Psychological | 2 | 2019 | 2575 | 0.120 |
Why?
|
Nutrition Surveys | 1 | 2021 | 1660 | 0.120 |
Why?
|
Case-Control Studies | 4 | 2022 | 21733 | 0.120 |
Why?
|
Time Factors | 10 | 2018 | 40038 | 0.120 |
Why?
|
Aged, 80 and over | 5 | 2020 | 57744 | 0.120 |
Why?
|
Alaska | 1 | 2014 | 68 | 0.120 |
Why?
|
Appointments and Schedules | 1 | 2018 | 417 | 0.120 |
Why?
|
Emotions | 2 | 2019 | 2656 | 0.120 |
Why?
|
Cardiovascular Diseases | 2 | 2023 | 15142 | 0.120 |
Why?
|
Health Services Needs and Demand | 2 | 2012 | 1411 | 0.110 |
Why?
|
Quality Assurance, Health Care | 3 | 2008 | 2211 | 0.110 |
Why?
|
Attitude to Health | 2 | 2020 | 2052 | 0.110 |
Why?
|
Prospective Studies | 6 | 2020 | 53250 | 0.110 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2005 | 2407 | 0.110 |
Why?
|
Sexual Behavior | 1 | 2022 | 2049 | 0.100 |
Why?
|
Statistics, Nonparametric | 1 | 2017 | 2883 | 0.100 |
Why?
|
Child | 14 | 2023 | 77637 | 0.100 |
Why?
|
Depressive Disorder | 1 | 2004 | 3744 | 0.100 |
Why?
|
Multi-Institutional Systems | 1 | 2010 | 43 | 0.100 |
Why?
|
Prenatal Care | 1 | 2018 | 1092 | 0.100 |
Why?
|
Population Surveillance | 3 | 2011 | 2614 | 0.100 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 25032 | 0.090 |
Why?
|
Patient Credit and Collection | 1 | 2010 | 16 | 0.090 |
Why?
|
Anthropology, Cultural | 1 | 2010 | 99 | 0.090 |
Why?
|
Logistic Models | 3 | 2018 | 13404 | 0.090 |
Why?
|
Pregnancy | 5 | 2023 | 29140 | 0.090 |
Why?
|
Empathy | 1 | 2014 | 474 | 0.090 |
Why?
|
Poverty Areas | 1 | 2011 | 275 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6539 | 0.090 |
Why?
|
Community-Based Participatory Research | 1 | 2011 | 214 | 0.090 |
Why?
|
Narration | 1 | 2012 | 212 | 0.090 |
Why?
|
Anxiety | 1 | 2004 | 4288 | 0.090 |
Why?
|
Tetrazolium Salts | 1 | 2009 | 96 | 0.090 |
Why?
|
Mycobacterium avium Complex | 1 | 2009 | 60 | 0.090 |
Why?
|
Culture Media | 2 | 2009 | 909 | 0.090 |
Why?
|
Isoniazid | 1 | 2011 | 274 | 0.090 |
Why?
|
Clarithromycin | 1 | 2009 | 86 | 0.080 |
Why?
|
Practice Guidelines as Topic | 3 | 2011 | 7270 | 0.080 |
Why?
|
Mental Health Services | 1 | 2020 | 1643 | 0.080 |
Why?
|
Pneumonectomy | 1 | 2016 | 1098 | 0.080 |
Why?
|
Depression | 1 | 2008 | 7760 | 0.080 |
Why?
|
Mothers | 1 | 2019 | 2166 | 0.080 |
Why?
|
Immune Reconstitution Inflammatory Syndrome | 1 | 2008 | 66 | 0.080 |
Why?
|
Confidence Intervals | 2 | 2012 | 2971 | 0.080 |
Why?
|
Public Health Administration | 2 | 2007 | 240 | 0.080 |
Why?
|
Delivery of Health Care | 3 | 2012 | 5319 | 0.080 |
Why?
|
Age Distribution | 2 | 2004 | 2899 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2014 | 3921 | 0.080 |
Why?
|
Multivariate Analysis | 2 | 2016 | 12243 | 0.070 |
Why?
|
Microbiological Techniques | 1 | 2008 | 102 | 0.070 |
Why?
|
Survival Analysis | 2 | 2017 | 10251 | 0.070 |
Why?
|
Peer Group | 1 | 2011 | 635 | 0.070 |
Why?
|
Siphonaptera | 1 | 2006 | 7 | 0.070 |
Why?
|
Ectoparasitic Infestations | 1 | 2006 | 12 | 0.070 |
Why?
|
Cost of Illness | 2 | 2023 | 1859 | 0.070 |
Why?
|
Treatment Failure | 3 | 2016 | 2617 | 0.070 |
Why?
|
Education, Medical, Continuing | 1 | 2012 | 840 | 0.070 |
Why?
|
Infant, Newborn | 4 | 2018 | 25609 | 0.070 |
Why?
|
Efficiency, Organizational | 1 | 2010 | 695 | 0.070 |
Why?
|
Superinfection | 1 | 2006 | 65 | 0.070 |
Why?
|
Urban Health | 1 | 2008 | 547 | 0.070 |
Why?
|
Medical Errors | 1 | 2014 | 1297 | 0.070 |
Why?
|
Patient Discharge | 1 | 2018 | 3317 | 0.070 |
Why?
|
Substance-Related Disorders | 2 | 2020 | 4254 | 0.070 |
Why?
|
Medicare | 1 | 2023 | 6565 | 0.060 |
Why?
|
Health Policy | 2 | 2022 | 2662 | 0.060 |
Why?
|
Information Systems | 1 | 2007 | 410 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2022 | 13980 | 0.060 |
Why?
|
Health Plan Implementation | 2 | 2007 | 351 | 0.060 |
Why?
|
Professional Competence | 1 | 2008 | 447 | 0.060 |
Why?
|
Comorbidity | 3 | 2023 | 10380 | 0.060 |
Why?
|
Databases, Factual | 2 | 2017 | 7729 | 0.060 |
Why?
|
Drug Administration Schedule | 4 | 2016 | 4931 | 0.060 |
Why?
|
Length of Stay | 1 | 2018 | 6311 | 0.060 |
Why?
|
Treatment Refusal | 1 | 2008 | 421 | 0.060 |
Why?
|
Capreomycin | 1 | 2004 | 14 | 0.060 |
Why?
|
Patients | 1 | 2011 | 899 | 0.060 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2007 | 469 | 0.060 |
Why?
|
Drug Resistance, Microbial | 2 | 2005 | 860 | 0.060 |
Why?
|
CD4 Lymphocyte Count | 1 | 2010 | 2560 | 0.060 |
Why?
|
Blood Glucose | 1 | 2018 | 6259 | 0.060 |
Why?
|
Sex Factors | 1 | 2017 | 10394 | 0.060 |
Why?
|
Clinical Protocols | 3 | 2014 | 1459 | 0.060 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2010 | 1951 | 0.060 |
Why?
|
Feasibility Studies | 1 | 2013 | 5078 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2020 | 4467 | 0.060 |
Why?
|
Primary Prevention | 1 | 2010 | 1167 | 0.050 |
Why?
|
Metabolism, Inborn Errors | 1 | 2005 | 288 | 0.050 |
Why?
|
Contact Tracing | 1 | 2005 | 273 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2013 | 2265 | 0.050 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2010 | 6030 | 0.050 |
Why?
|
Ambulatory Care | 3 | 2008 | 2707 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2016 | 39001 | 0.050 |
Why?
|
Information Dissemination | 1 | 2010 | 1099 | 0.050 |
Why?
|
Lesotho | 1 | 2022 | 70 | 0.050 |
Why?
|
Self Care | 1 | 2007 | 786 | 0.050 |
Why?
|
Point-of-Care Systems | 1 | 2010 | 1177 | 0.050 |
Why?
|
Incidence | 4 | 2023 | 20948 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2009 | 1738 | 0.050 |
Why?
|
Insurance Benefits | 1 | 2023 | 183 | 0.050 |
Why?
|
Inservice Training | 1 | 2004 | 392 | 0.050 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2007 | 1320 | 0.050 |
Why?
|
Preventive Health Services | 1 | 2006 | 575 | 0.050 |
Why?
|
Regression Analysis | 1 | 2011 | 6457 | 0.050 |
Why?
|
Respiratory Insufficiency | 1 | 2010 | 1199 | 0.050 |
Why?
|
Risk Assessment | 3 | 2017 | 23327 | 0.050 |
Why?
|
Odds Ratio | 2 | 2012 | 9848 | 0.050 |
Why?
|
Atrial Flutter | 1 | 2023 | 263 | 0.050 |
Why?
|
Mutation | 2 | 2005 | 29777 | 0.050 |
Why?
|
Pelvic Bones | 1 | 2003 | 265 | 0.050 |
Why?
|
Antibodies, Viral | 1 | 2012 | 3175 | 0.050 |
Why?
|
Interview, Psychological | 1 | 2004 | 812 | 0.050 |
Why?
|
HIV-1 | 2 | 2009 | 6939 | 0.050 |
Why?
|
Age Factors | 1 | 2017 | 18355 | 0.050 |
Why?
|
Magnesium | 1 | 2004 | 813 | 0.050 |
Why?
|
Neonatal Screening | 1 | 2005 | 590 | 0.050 |
Why?
|
Socioeconomic Factors | 2 | 2011 | 7784 | 0.050 |
Why?
|
Family Characteristics | 1 | 2005 | 1000 | 0.040 |
Why?
|
Communication | 1 | 2014 | 3748 | 0.040 |
Why?
|
Cross Infection | 1 | 2008 | 1416 | 0.040 |
Why?
|
Food Preferences | 1 | 2022 | 399 | 0.040 |
Why?
|
Radiography | 1 | 2010 | 7010 | 0.040 |
Why?
|
Cooperative Behavior | 2 | 2020 | 1503 | 0.040 |
Why?
|
Medical Records | 1 | 2004 | 1412 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2014 | 4370 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2012 | 5316 | 0.040 |
Why?
|
Nutrition Policy | 1 | 2022 | 488 | 0.040 |
Why?
|
Self Efficacy | 1 | 2022 | 615 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2008 | 15526 | 0.040 |
Why?
|
Survival Rate | 1 | 2012 | 12786 | 0.040 |
Why?
|
Drug Resistance, Bacterial | 1 | 2005 | 1030 | 0.040 |
Why?
|
Hospitalization | 1 | 2017 | 10259 | 0.040 |
Why?
|
Capacity Building | 1 | 2020 | 248 | 0.040 |
Why?
|
Secondary Prevention | 2 | 2016 | 1529 | 0.040 |
Why?
|
Electromyography | 1 | 2003 | 1378 | 0.040 |
Why?
|
Ischemic Attack, Transient | 1 | 2023 | 934 | 0.040 |
Why?
|
Decision Making | 1 | 2011 | 3887 | 0.040 |
Why?
|
Developed Countries | 1 | 2020 | 437 | 0.040 |
Why?
|
Patient Selection | 1 | 2009 | 4210 | 0.040 |
Why?
|
Water | 1 | 2023 | 1394 | 0.040 |
Why?
|
Health Planning | 1 | 1998 | 237 | 0.040 |
Why?
|
Evidence-Based Practice | 1 | 2020 | 500 | 0.030 |
Why?
|
Korea | 2 | 2005 | 99 | 0.030 |
Why?
|
Morals | 1 | 1998 | 284 | 0.030 |
Why?
|
Quality Control | 2 | 2008 | 841 | 0.030 |
Why?
|
Unsafe Sex | 1 | 2016 | 220 | 0.030 |
Why?
|
National Health Programs | 2 | 2010 | 445 | 0.030 |
Why?
|
Risk | 2 | 2016 | 9677 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2005 | 4803 | 0.030 |
Why?
|
Learning | 1 | 2022 | 1710 | 0.030 |
Why?
|
World Health Organization | 1 | 1998 | 1317 | 0.030 |
Why?
|
Diglycerides | 1 | 1993 | 176 | 0.030 |
Why?
|
Recurrence | 2 | 2016 | 8337 | 0.030 |
Why?
|
Georgia (Republic) | 1 | 2011 | 41 | 0.030 |
Why?
|
Tuberculin Test | 1 | 2012 | 214 | 0.030 |
Why?
|
Ceramides | 1 | 1993 | 199 | 0.030 |
Why?
|
Endemic Diseases | 1 | 2012 | 182 | 0.020 |
Why?
|
Lung | 1 | 2010 | 9858 | 0.020 |
Why?
|
Protein-Energy Malnutrition | 1 | 2012 | 188 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2012 | 588 | 0.020 |
Why?
|
Drug Therapy | 1 | 2014 | 496 | 0.020 |
Why?
|
Complement Activation | 1 | 1993 | 453 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 10940 | 0.020 |
Why?
|
Siberia | 1 | 2009 | 32 | 0.020 |
Why?
|
Risk-Taking | 1 | 2016 | 986 | 0.020 |
Why?
|
Retreatment | 1 | 2012 | 609 | 0.020 |
Why?
|
Disease Outbreaks | 2 | 2012 | 1771 | 0.020 |
Why?
|
Geographic Information Systems | 1 | 2012 | 281 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2010 | 426 | 0.020 |
Why?
|
Hospitals, Chronic Disease | 1 | 2008 | 8 | 0.020 |
Why?
|
Disease Management | 1 | 1999 | 2459 | 0.020 |
Why?
|
Bacteriology | 1 | 2007 | 10 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2008 | 20121 | 0.020 |
Why?
|
HIV Seronegativity | 1 | 2008 | 211 | 0.020 |
Why?
|
Demography | 1 | 2012 | 1653 | 0.020 |
Why?
|
Internet | 2 | 2010 | 3058 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 1999 | 5388 | 0.020 |
Why?
|
Education | 1 | 2008 | 543 | 0.020 |
Why?
|
Rural Health | 1 | 2006 | 305 | 0.020 |
Why?
|
ROC Curve | 1 | 2012 | 3527 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2013 | 6356 | 0.010 |
Why?
|
Haiti | 1 | 2006 | 553 | 0.010 |
Why?
|
Blood Specimen Collection | 1 | 2005 | 246 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2023 | 6485 | 0.010 |
Why?
|
Leg Length Inequality | 1 | 2003 | 55 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8385 | 0.010 |
Why?
|
Sacroiliac Joint | 1 | 2003 | 62 | 0.010 |
Why?
|
Acidosis | 1 | 2005 | 271 | 0.010 |
Why?
|
Interdisciplinary Communication | 1 | 2008 | 950 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2009 | 2453 | 0.010 |
Why?
|
Community Health Centers | 1 | 2005 | 428 | 0.010 |
Why?
|
Diet | 1 | 2020 | 7930 | 0.010 |
Why?
|
Drug Tolerance | 1 | 2003 | 376 | 0.010 |
Why?
|
Prognosis | 2 | 2012 | 29052 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 35409 | 0.010 |
Why?
|
Ambulatory Care Facilities | 1 | 2007 | 934 | 0.010 |
Why?
|
Stroke | 1 | 2023 | 9975 | 0.010 |
Why?
|
Animals | 3 | 2009 | 168660 | 0.010 |
Why?
|
Algorithms | 2 | 2012 | 13869 | 0.010 |
Why?
|
Radiography, Abdominal | 1 | 2003 | 537 | 0.010 |
Why?
|
China | 1 | 2005 | 2243 | 0.010 |
Why?
|
Life Style | 1 | 2011 | 3833 | 0.010 |
Why?
|
Heart Failure | 1 | 2023 | 10896 | 0.010 |
Why?
|
Amino Acids | 1 | 2005 | 1733 | 0.010 |
Why?
|
Quality Improvement | 1 | 2014 | 3750 | 0.010 |
Why?
|
Sampling Studies | 1 | 2000 | 622 | 0.010 |
Why?
|
Research Design | 1 | 2014 | 5983 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2005 | 2203 | 0.010 |
Why?
|
Fatty Acids | 1 | 2005 | 1809 | 0.010 |
Why?
|
Anti-Retroviral Agents | 1 | 2006 | 1714 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2009 | 3229 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2008 | 3530 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2010 | 14714 | 0.010 |
Why?
|
Complement C9 | 1 | 1993 | 16 | 0.010 |
Why?
|
Virulence Factors, Bordetella | 1 | 1993 | 156 | 0.010 |
Why?
|
Pertussis Toxin | 1 | 1993 | 178 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2005 | 3850 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1993 | 897 | 0.010 |
Why?
|
Phosphatidylcholines | 1 | 1993 | 410 | 0.010 |
Why?
|
Genotype | 1 | 2005 | 12944 | 0.010 |
Why?
|
Molecular Weight | 1 | 1993 | 2253 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1993 | 1802 | 0.010 |
Why?
|
Mental Disorders | 1 | 2008 | 6593 | 0.000 |
Why?
|
Protein Kinase C | 1 | 1993 | 1227 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2006 | 15281 | 0.000 |
Why?
|
Phosphorylation | 1 | 1993 | 8436 | 0.000 |
Why?
|
Mice | 1 | 1993 | 81154 | 0.000 |
Why?
|